Concepedia

Jack Geduldig

JG

Statistics

Publications

9

Citations

2.4K

H-Index

9

Active since

2018

Affiliations

Dana-Farber Cancer Institute(Current)

Brigham and Women's Hospital

Broad Institute

Sorbonne Université

Harvard University

Jack Geduldig is an author at Dana-Farber Cancer Institute specializing in oncology, medicine, and molecular oncology.

Publications per year

2018–2024

9

Publications

9

Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial

Derin B. Keskin, Annabelle Anandappa, Jing Sun et al. · Nature · 2018 · 1.4K citations · Full text

Medicine, Immunology, Oncology +16

Mechanisms and therapeutic implications of hypermutation in gliomas

Mehdi Touat, Yvonne Y. Li, Adam N. Boynton et al. · Nature · 2020 · 702 citations · Full text

Medicine, Molecular Genetics, Oncology +12

Single-Cell RNA-Seq Reveals Cellular Hierarchies and Impaired Developmental Trajectories in Pediatric Ependymoma

Johannes Gojo, Bernhard Englinger, Li Jiang et al. · Cancer Cell · 2020 · 161 citations · Full text

Life Sciences, Developmental Biology, Molecular Biology +15

Inaugural Results of the Individualized Screening Trial of Innovative Glioblastoma Therapy: A Phase II Platform Trial for Newly Diagnosed Glioblastoma Using Bayesian Adaptive Randomization

Rifaquat Rahman, Lorenzo Trippa, Eudocia Q. Lee et al. · Journal of Clinical Oncology · 2023 · 50 citations

Medicine, Biostatistics, Oncology +17

Functional drug susceptibility testing using single-cell mass predicts treatment outcome in patient-derived cancer neurosphere models

Max A. Stockslager, Seth Malinowski, Mehdi Touat et al. · Cell Reports · 2021 · 37 citations · Full text

Medicine, Cancer Biology, Oncology +17

1–5 of 9